Integra Lifesciences Holdings (IART) EPS (Weighted Average and Diluted) (2016 - 2026)
Integra Lifesciences Holdings' EPS (Weighted Average and Diluted) history spans 17 years, with the latest figure at -$0.02 for Q4 2025.
- On a quarterly basis, EPS (Weighted Average and Diluted) fell 108.0% to -$0.02 in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.73, a 7377.78% decrease, with the full-year FY2025 number at -$6.74, down 7388.89% from a year prior.
- EPS (Weighted Average and Diluted) hit -$0.02 in Q4 2025 for Integra Lifesciences Holdings, up from -$0.07 in the prior quarter.
- Over the last five years, EPS (Weighted Average and Diluted) for IART hit a ceiling of $0.63 in Q4 2022 and a floor of -$6.31 in Q2 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.09 across 5 years, with a median of $0.25 in 2023.
- Biggest five-year swings in EPS (Weighted Average and Diluted): soared 9511.78% in 2021 and later plummeted 3843.75% in 2025.
- Tracing IART's EPS (Weighted Average and Diluted) over 5 years: stood at $0.53 in 2021, then grew by 18.87% to $0.63 in 2022, then tumbled by 60.32% to $0.25 in 2023, then changed by 0.0% to $0.25 in 2024, then tumbled by 108.0% to -$0.02 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for IART at -$0.02 in Q4 2025, -$0.07 in Q3 2025, and -$6.31 in Q2 2025.